Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Clin Pharmacokinet. 2019 Oct;58(10):1281–1294. doi: 10.1007/s40262-019-00750-8

Figure 1.

Figure 1.

The workflow for inclusion of drugs in established and newly-approved drug lists. The metabolism pathways were analyzed using the unique compounds from “top 200” most prescribed medications in 2014 (established drugs; n=165) as well as FDA approved drugs from “2005–2016” (newly-approved drugs; n=249). n, denotes the number of compounds analyzed at each stage.